22
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
6.523
Exchange
XHKG - Hong Kong Exchange
10 %
Last period ROIC
-6%
ROIC has decreased in 5 years
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also WuXi Biologics
Company Analysis
2269.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2269.HK financial analysis by Eyestock methodology
Valuation
2269.HK valuation using historical relative method
Statements
2269.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2269.HK dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
WuXi Biologics`s ROIC for the last twelve months ended 2023-12-31 is 10 %
